Product
The Company
About Emotra
Board and management
Investors
For investors
News archive
Press releases
Financial reports
Newsletters
Documents
Shareholder meetings
Emissions
Contact
Contact us
Emotra organization
Select Page
Archives
Archives
Select Month
August 2023
February 2023
November 2022
September 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
February 2021
December 2020
November 2020
October 2020
September 2020
August 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
November 2019
October 2019
September 2019
August 2019
June 2019
May 2019
April 2019
March 2019
February 2019
November 2018
October 2018
September 2018
August 2018
July 2018
May 2018
April 2018
March 2018
February 2018
December 2017
October 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
April 2016
March 2016
February 2016
January 2016
November 2015
October 2015
September 2015
August 2015
July 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
October 2014
September 2014
August 2014
June 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
June 2013
May 2013
April 2013
March 2013
February 2013
Search
Search for:
Svenska
For investors
News archive
Press releases
Financial reports
Newsletters
Documents
Shareholder meetings
Emissions
The first stage of our clinical study has now been completed
by
Claes Holmberg
|
Mar 11, 2016
|
INVESTORS
160311 – Emotra – PM – First stage of study completed
←
Previous post
Next post
→
